{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:41:01Z","timestamp":1765806061545},"reference-count":107,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>Viral diseases have a significant impact on human health, and three novel coronaviruses (CoV) have emerged during the 21st century. In this review, we have emphasized the potential of herbal substances with antiviral effects. Our investigation focused on the features and prospects of viral disease treatment, with a particular emphasis on proinflammatory cytokines. We conducted comprehensive searches of various databases, including Science Direct, CABI Direct, Web of Science, PubMed, and Scopus. Cytokine storm mechanisms play a crucial role in inducing a pro-inflammatory response by triggering the expression of cytokines and chemokines. This response leads to the recruitment of leukocytes and promotes antiviral effects, forming the first line of defense against viruses. Numerous studies have investigated the use of herbal medicine candidates as immunomodulators or antivirals. However, cytokine-storm-targeted therapy is recommended for patients with acute respiratory distress syndrome caused by SARS-CoV to survive severe pulmonary failure. Our reviews have demonstrated that herbal formulations could serve as alternative medicines and significantly reduce complicated viral infections. Furthermore, they hold promising potential as specific antiviral agents in experimental animal models.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929867330666230125121758","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T12:02:10Z","timestamp":1674648130000},"page":"393-409","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Herbal Substances with Antiviral Effects: Features and Prospects for the Treatment of Viral Diseases with Emphasis on Pro-Inflammatory Cytokines"],"prefix":"10.2174","volume":"31","author":[{"given":"Geir","family":"Bj\u00f8rklund","sequence":"first","affiliation":[{"name":"Department of Research, Council for Nutritional and Environmental Medicine (CONEM), Mo i Rana, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Lysiuk","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy and Botany, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine"},{"name":"CONEM Ukraine Life Science Research Group, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuliya","family":"Semenova","sequence":"additional","affiliation":[{"name":"School of Medicine, Nazarbayev University , Astana, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larysa","family":"Lenchyk","sequence":"additional","affiliation":[{"name":"Department of Research, National University of Pharmacy, Kharkiv, Ukraine"},{"name":"CONEM Ukraine Pharmacognosy and Natural Product Chemistry Research Group, National University of Pharmacy, Kharkiv, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Dub","sequence":"additional","affiliation":[{"name":"Andrei Krupynskyi Lviv Medical Academy, Lviv, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica Daniela","family":"Do\u015fa","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Hangan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"Cao X.","year":"2020","unstructured":"Cao X.; COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol 2020,20(5),269-270","journal-title":"Nat Rev Immunol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1080\/21645515.2020.1735227","volume":"16","author":"Dhama K.","year":"2020","unstructured":"Dhama K.; Sharun K.; Tiwari R.; Dadar M.; Malik Y.S.; Singh K.P.; Chaicumpa W.; COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum Vaccin Immunother 2020,16(6),1232-1238","journal-title":"Hum Vaccin Immunother"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/01652176.2020.1727993","volume":"40","author":"Malik Y.S.","year":"2020","unstructured":"Malik Y.S.; Sircar S.; Bhat S.; Sharun K.; Dhama K.; Dadar M.; Tiwari R.; Chaicumpa W.; Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments. Vet Q 2020,40(1),68-76","journal-title":"Vet Q"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.jaccas.2020.04.001","volume":"2","author":"Chau V.Q.","year":"2020","unstructured":"Chau V.Q.; Oliveros E.; Mahmood K.; Singhvi A.; Lala A.; Moss N.; Gidwani U.; Mancini D.M.; Pinney S.P.; Parikh A.; The imperfect cytokine storm. JACC Case Rep 2020,2(9),1315-1320","journal-title":"JACC Case Rep"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.gastro.2003.08.001","volume":"125","author":"Leung W.K.","year":"2003","unstructured":"Leung W.K.; To K.; Chan P.K.S.; Chan H.L.Y.; Wu A.K.L.; Lee N.; Yuen K.Y.; Sung J.J.Y.; Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 2003,125(4),1011-1017","journal-title":"Gastroenterology"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41401-020-0483-6","volume":"41","author":"Su H.","year":"2020","unstructured":"Su H.; Yao S.; Zhao W.; Li M.; Liu J.; Shang W.; Xie H.; Ke C.; Hu H.; Gao M.; Yu K.; Liu H.; Shen J.; Tang W.; Zhang L.; Xiao G.; Ni L.; Wang D.; Zuo J.; Jiang H.; Bai F.; Wu Y.; Ye Y.; Xu Y.; Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta Pharmacol Sin 2020,41(9),1167-1177","journal-title":"Acta Pharmacol Sin"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/1743-422X-8-538","volume":"8","author":"He W.","year":"2011","unstructured":"He W.; Han H.; Wang W.; Gao B.; Anti-influenza virus effect of aqueous extracts from dandelion. Virol J 2011,8(1),538","journal-title":"Virol J"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"6180","DOI":"10.1128\/JVI.79.10.6180-6193.2005","volume":"79","author":"Tang B.S.F.","year":"2005","unstructured":"Tang B.S.F.; Chan K.; Cheng V.C.C.; Woo P.C.Y.; Lau S.K.P.; Lam C.C.K.; Chan T.; Wu A.K.L.; Hung I.F.N.; Leung S.; Yuen K.; Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E. J Virol 2005,79(10),6180-6193","journal-title":"J Virol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1080\/22221751.2020.1736644","volume":"9","author":"Fung S.Y.","year":"2020","unstructured":"Fung S.Y.; Yuen K.S.; Ye Z.W.; Chan C.P.; Jin D.Y.; A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerg Microbes Infect 2020,9(1),558-570","journal-title":"Emerg Microbes Infect"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"581840","DOI":"10.3389\/fphar.2020.581840","volume":"11","author":"Silveira D.","year":"2020","unstructured":"Silveira D.; Prieto-Garcia J.M.; Boylan F.; Estrada O.; Fonseca-Bazzo Y.M.; Jamal C.M.; Magalh\u00e3es P.O.; Pereira E.O.; Tomczyk M.; Heinrich M.; COVID-19: Is there evidence for the use of herbal medicines as adjuvant symptomatic therapy? Front Pharmacol 2020,11,581840","journal-title":"Front Pharmacol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"104799","DOI":"10.1016\/j.micpath.2021.104799","volume":"153","author":"Darif D.","year":"2021","unstructured":"Darif D.; Hammi I.; Kihel A.; El Idrissi Saik I.; Guessous F.; Akarid K.; The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong? Microb Pathog 2021,153,104799","journal-title":"Microb Pathog"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1684\/ecn.2020.0451","volume":"31","author":"Moradian N.","year":"2020","unstructured":"Moradian N.; Gouravani M.; Salehi M.A.; Heidari A.; Shafeghat M.; Hamblin M.R.; Rezaei N.; Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality. Eur Cytokine Netw 2020,31(3),81-93","journal-title":"Eur Cytokine Netw"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","volume":"221","author":"Wang F.","year":"2020","unstructured":"Wang F.; Nie J.; Wang H.; Zhao Q.; Xiong Y.; Deng L.; Song S.; Ma Z.; Mo P.; Zhang Y.; Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis 2020,221(11),1762-1769","journal-title":"J Infect Dis"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1128\/MMBR.65.1.131-150.2001","volume":"65","author":"Mogensen T.H.","year":"2001","unstructured":"Mogensen T.H.; Paludan S.R.; Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev 2001,65(1),131-150","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"e0162954","DOI":"10.1371\/journal.pone.0162954","volume":"11","author":"Chen Y.","year":"2016","unstructured":"Chen Y.; Cao J.; Zhang X.; The role of cytokine PF4 in the antiviral immune response of shrimp. PLoS One 2016,11(9),e0162954","journal-title":"PLoS One"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-540-33397-5_2","volume":"303","author":"Salazar-Mather T.","year":"2006","unstructured":"Salazar-Mather T.; Hokeness K.; Cytokine and chemokine networks: pathways to antiviral defense. Chemokines Viral Infect 2006,303,29-46","journal-title":"Chemokines Viral Infect"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"Mehta P.","year":"2020","unstructured":"Mehta P.; McAuley D.F.; Brown M.; Sanchez E.; Tattersall R.S.; Manson J.J.; Collaboration H.; COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020,395(10229),1033-1034","journal-title":"Lancet"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/MMBR.05015-11","volume":"76","author":"Tisoncik J.R.","year":"2012","unstructured":"Tisoncik J.R.; Korth M.J.; Simmons C.P.; Farrar J.; Martin T.R.; Katze M.G.; Into the eye of the cytokine storm. Microbiol Mol Biol Rev 2012,76(1),16-32","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.eng.2020.03.006","volume":"7","author":"Zhang Y.","year":"2021","unstructured":"Zhang Y.; Yu L.; Tang L.; Zhu M.; Jin Y.; Wang Z.; Li L.; A promising anti-cytokine-storm targeted therapy for COVID-19: the artificial-liver blood-purification system. Engineering (Beijing) 2021,7(1),11-13","journal-title":"Engineering (Beijing)"},{"year":"2020","author":"Shi Y.","key":"ref=20","unstructured":"Shi Y.; Wang Y.; Shao C.; Huang J.; Gan J.; Huang X.; Bucci E.; Piacentini M.; Ippolito G.; Melino G.; COVID-19 infection: The perspectives on immune responses. Cell Death Differ., 2020, 27, 1451\u20131454. 2020"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"131594","DOI":"10.1016\/j.foodchem.2021.131594","volume":"373","author":"Bahun M.","year":"2022","unstructured":"Bahun M.; Juki\u0107 M.; Oblak D.; Kranjc L.; Bajc G.; Butala M.; Bozovi\u010dar K.; Bratkovi\u010d T.; Podlipnik \u010c.; Poklar Ulrih N.; Inhibition of the SARS-CoV-2 3CL main protease by plant polyphenols. Food Chem 2022,373(Pt B),131594","journal-title":"Food Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"13009","DOI":"10.3390\/ijms222313009","volume":"22","author":"Tang X.D.","year":"2021","unstructured":"Tang X.D.; Ji T.T.; Dong J.R.; Feng H.; Chen F.Q.; Chen X.; Zhao H.Y.; Chen D.K.; Ma W.T.; Pathogenesis and treatment of cytokine storm induced by infectious diseases. Int J Mol Sci 2021,22(23),13009","journal-title":"Int J Mol Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cmi.2015.74","volume":"13","author":"Liu Q.","year":"2016","unstructured":"Liu Q.; Zhou Y.; Yang Z.; The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol Immunol 2016,13(1),3-10","journal-title":"Cell Mol Immunol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3390\/molecules21040465","volume":"21","author":"Schwager J.","year":"2016","unstructured":"Schwager J.; Richard N.; Fowler A.; Seifert N.; Raederstorff D.; Carnosol and related substances modulate chemokine and cytokine production in macrophages and chondrocytes. Molecules 2016,21(4),465","journal-title":"Molecules"},{"key":"ref=25","unstructured":"Petric, D. Cytokine storm in COVID-19. Mol. Biol., 2020. Available from: https:\/\/www.researchgate.net\/publication\/340463773_Cytokine_storm_in_COVID-19"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1089\/107999099313451","volume":"19","author":"Tovey M.G.","year":"1999","unstructured":"Tovey M.G.; Meritet J.F.; Guymarho J.; Maury C.; Mucosal cytokine therapy: marked antiviral and antitumor activity. J Interferon Cytokine Res 1999,19(8),911-921","journal-title":"J Interferon Cytokine Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/bcpt.13650","volume":"130","author":"Pandolfi S.","year":"2022","unstructured":"Pandolfi S.; Chirumbolo S.; Ricevuti G.; Valdenassi L.; Bj\u00f8rklund G.; Lysiuk R.; Do\u015fa M.D.; Lenchyk L.; Fazio S.; Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality. Time for a suitable proposal. Basic Clin Pharmacol Toxicol 2022,130(2),225-239","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"104761","DOI":"10.1016\/j.phrs.2020.104761","volume":"156","author":"Runfeng L.","year":"2020","unstructured":"Runfeng L.; Yunlong H.; Jicheng H.; Weiqi P.; Qinhai M.; Yongxia S.; Chufang L.; Jin Z.; Zhenhua J.; Haiming J.; Kui Z.; Shuxiang H.; Jun D.; Xiaobo L.; Xiaotao H.; Lin W.; Nanshan Z.; Zifeng Y.; Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol Res 2020,156,104761","journal-title":"Pharmacol Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1080\/07391102.2020.1758790","volume":"39","author":"Aanouz I.","year":"2021","unstructured":"Aanouz I.; Belhassan A.; El-Khatabi K.; Lakhlifi T.; El-ldrissi M.; Bouachrine M.; Moroccan medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations. J Biomol Struct Dyn 2021,39(8),2971-2979","journal-title":"J Biomol Struct Dyn"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3760\/cma.j.issn.0366-6999.20132029","volume":"127","author":"Wang X.","year":"2014","unstructured":"Wang X.; Liu Z.; Prevention and treatment of viral respiratory infections by traditional Chinese herbs. Chin Med J (Engl) 2014,127(7),1344-1350","journal-title":"Chin Med J (Engl)"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e28093","DOI":"10.1371\/journal.pone.0028093","volume":"6","author":"Chen W.","year":"2011","unstructured":"Chen W.; Lim C.E.D.; Kang H.J.; Liu J.; Chinese herbal medicines for the treatment of type A H1N1 influenza: a systematic review of randomized controlled trials. PLoS One 2011,6(12),e28093","journal-title":"PLoS One"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13643-020-01343-4","volume":"9","author":"Li Y.","year":"2020","unstructured":"Li Y.; Liu X.; Guo L.; Li J.; Zhong D.; Zhang Y.; Clarke M.; Jin R.; Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis. Syst Rev 2020,9(1),75","journal-title":"Syst Rev"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/acm.2020.0310","volume":"27","author":"Zhou L.","year":"2021","unstructured":"Zhou L.; Wang J.; Xie R.; Pakhale S.; Krewski D.; Cameron D.W.; Wen S.W.; The effects of traditional Chinese medicine as an auxiliary treatment for COVID-19: a systematic review and meta-analysis. J Altern Complement Med 2021,27(3),225-237","journal-title":"J Altern Complement Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jep.2013.08.056","volume":"150","author":"Liu Q.","year":"2013","unstructured":"Liu Q.; Lu L.; Hua M.; Xu Y.; Xiong H.; Hou W.; Yang Z.; Jiawei-Yupingfeng-Tang, a Chinese herbal formula, inhibits respiratory viral infections in vitro and in vivo. J Ethnopharmacol 2013,150(2),521-528","journal-title":"J Ethnopharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/ptr.6024","volume":"32","author":"Akram M.","year":"2018","unstructured":"Akram M.; Tahir I.M.; Shah S.M.A.; Mahmood Z.; Altaf A.; Ahmad K.; Munir N.; Daniyal M.; Nasir S.; Mehboob H.; Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review. Phytother Res 2018,32(5),811-822","journal-title":"Phytother Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.3390\/molecules22091466","volume":"22","author":"Dong Z.","year":"2017","unstructured":"Dong Z.; Lu X.; Tong X.; Dong Y.; Tang L.; Liu M.; Forsythiae fructus: A review on its phytochemistry, quality control, pharmacology and pharmacokinetics. Molecules 2017,22(9),1466","journal-title":"Molecules"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/00498254.2016.1193262","volume":"47","author":"Cheng Y.","year":"2017","unstructured":"Cheng Y.; Liang X.; Feng L.; Liu D.; Qin M.; Liu S.; Liu G.; Dong M.; Effects of phillyrin and forsythoside A on rat cytochrome P450 activities in vivo and in vitro. Xenobiotica 2017,47(4),297-303","journal-title":"Xenobiotica"},{"key":"ref=38","first-page":"CD004882","volume":"10","author":"Liu X.","year":"2012","unstructured":"Liu X.; Zhang M.; He L.; Li Y.; Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). Cochrane Database Syst Rev 2012,10(10),CD004882","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11655-020-3192-6","volume":"26","author":"Luo H.","year":"2020","unstructured":"Luo H.; Tang Q.; Shang Y.; Liang S.; Yang M.; Robinson N.; Liu J.; Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin J Integr Med 2020,26(4),243-250","journal-title":"Chin J Integr Med"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1906206","DOI":"10.1002\/smll.201906206","volume":"16","author":"Tong T.","year":"2020","unstructured":"Tong T.; Hu H.; Zhou J.; Deng S.; Zhang X.; Tang W.; Fang L.; Xiao S.; Liang J.; Glycyrrhizic-acid-based carbon dots with high antiviral activity by multisite inhibition mechanisms. Small 2020,16(13),1906206","journal-title":"Small"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"104359","DOI":"10.1016\/j.compbiomed.2021.104359","volume":"133","author":"Kadioglu O.","year":"2021","unstructured":"Kadioglu O.; Saeed M.; Greten H.J.; Efferth T.; Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning. Comput Biol Med 2021,133,104359","journal-title":"Comput Biol Med"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"7940","DOI":"10.1016\/j.bmc.2010.09.035","volume":"18","author":"Ryu Y.B.","year":"2010","unstructured":"Ryu Y.B.; Jeong H.J.; Kim J.H.; Kim Y.M.; Park J.Y.; Kim D.; Naguyen T.T.H.; Park S.J.; Chang J.S.; Park K.H.; Rho M.C.; Lee W.S.; Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition. Bioorg Med Chem 2010,18(22),7940-7947","journal-title":"Bioorg Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jep.2008.03.018","volume":"118","author":"Lau K.M.","year":"2008","unstructured":"Lau K.M.; Lee K.M.; Koon C.M.; Cheung C.S.F.; Lau C.P.; Ho H.M.; Lee M.Y.H.; Au S.W.N.; Cheng C.H.K.; Lau C.B.S.; Tsui S.K.W.; Wan D.C.C.; Waye M.M.Y.; Wong K.B.; Wong C.K.; Lam C.W.K.; Leung P.C.; Fung K.P.; Immunomodulatory and anti-SARS activities of Houttuynia cordata. J Ethnopharmacol 2008,118(1),79-85","journal-title":"J Ethnopharmacol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.antiviral.2017.06.010","volume":"144","author":"Li T.","year":"2017","unstructured":"Li T.; Liu L.; Wu H.; Chen S.; Zhu Q.; Gao H.; Yu X.; Wang Y.; Su W.; Yao X.; Peng T.; Anti-herpes simplex virus type 1 activity of Houttuynoid A, a flavonoid from Houttuynia cordata Thunb. Antiviral Res 2017,144,273-280","journal-title":"Antiviral Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1021\/ol300017m","volume":"14","author":"Chen S.D.","year":"2012","unstructured":"Chen S.D.; Gao H.; Zhu Q.C.; Wang Y.Q.; Li T.; Mu Z.Q.; Wu H.L.; Peng T.; Yao X.S.; Houttuynoids A-E.; Houttuynoids A-E, anti-herpes simplex virus active flavonoids with novel skeletons from Houttuynia cordata. Org Lett 2012,14(7),1772-1775","journal-title":"Org Lett"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.antiviral.2005.07.002","volume":"68","author":"Lin C.W.","year":"2005","unstructured":"Lin C.W.; Tsai F.J.; Tsai C.H.; Lai C.C.; Wan L.; Ho T.Y.; Hsieh C.C.; Chao P.D.L.; Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res 2005,68(1),36-42","journal-title":"Antiviral Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1016\/j.bmcl.2012.04.081","volume":"22","author":"Yu M.S.","year":"2012","unstructured":"Yu M.S.; Lee J.; Lee J.M.; Kim Y.; Chin Y.W.; Jee J.G.; Keum Y.S.; Jeong Y.J.; Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorg Med Chem Lett 2012,22(12),4049-4054","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1440-1681.2006.04415.x","volume":"33","author":"Cheng P.W.","year":"2006","unstructured":"Cheng P.W.; Ng L.T.; Chiang L.C.; Lin C.C.; Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin Exp Pharmacol Physiol 2006,33(7),612-616","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1440-1681.2005.04270.x","volume":"32","author":"Chiang L.C.","year":"2005","unstructured":"Chiang L.C.; Ng L.T.; Cheng P.W.; Chiang W.; Lin C.C.; Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol 2005,32(10),811-816","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1055\/s-2003-42797","volume":"69","author":"Chiang L-C.","year":"2003","unstructured":"Chiang L-C.; Ng L.T.; Liu L-T.; Shieh D.E.; Lin C-C.; Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species. Planta Med 2003,69(8),705-709","journal-title":"Planta Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.fct.2006.06.007","volume":"45","author":"Cheng P.W.","year":"2007","unstructured":"Cheng P.W.; Chiang L.C.; Yen M.H.; Lin C.C.; Bupleurum kaoi inhibits Coxsackie B virus type 1 infection of CCFS-1 cells by induction of type I interferons expression. Food Chem Toxicol 2007,45(1),24-31","journal-title":"Food Chem Toxicol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1142\/S0192415X07004862","volume":"35","author":"Chang J.S.","year":"2007","unstructured":"Chang J.S.; Wang K.C.; Liu H.W.; Chen M.C.; Chiang L.C.; Lin C.C.; Sho-saiko-to (Xiao-Chai-Hu-Tang) and crude saikosaponins inhibit hepatitis B virus in a stable HBV-producing cell line. Am J Chin Med 2007,35(2),341-351","journal-title":"Am J Chin Med"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.phymed.2008.10.012","volume":"16","author":"Choi H.J.","year":"2009","unstructured":"Choi H.J.; Lim C.H.; Song J.H.; Baek S.H.; Kwon D.H.; Antiviral activity of raoulic acid from Raoulia australis against Picornaviruses. Phytomedicine 2009,16(1),35-39","journal-title":"Phytomedicine"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/1472-6882-12-214","volume":"12","author":"Zandi K.","year":"2012","unstructured":"Zandi K.; Teoh B.T.; Sam S.S.; Wong P.F.; Mustafa M.R.; AbuBakar S.; Novel antiviral activity of baicalein against dengue virus. BMC Complement Altern Med 2012,12(1),214","journal-title":"BMC Complement Altern Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.antiviral.2005.02.007","volume":"67","author":"Li S.","year":"2005","unstructured":"Li S.; Chen C.; Zhang H.; Guo H.; Wang H.; Wang L.; Zhang X.; Hua S.; Yu J.; Xiao P.; Li R.S.; Tan X.; Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res 2005,67(1),18-23","journal-title":"Antiviral Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1471-2180-13-187","volume":"13","author":"Lin L.T.","year":"2013","unstructured":"Lin L.T.; Chen T.Y.; Lin S.C.; Chung C.Y.; Lin T.C.; Wang G.H.; Anderson R.; Lin C.C.; Richardson C.D.; Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry. BMC Microbiol 2013,13(1),187","journal-title":"BMC Microbiol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1128\/JVI.01492-10","volume":"85","author":"Lin L.T.","year":"2011","unstructured":"Lin L.T.; Chen T.Y.; Chung C.Y.; Noyce R.S.; Grindley T.B.; McCormick C.; Lin T.C.; Wang G.H.; Lin C.C.; Richardson C.D.; Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread. J Virol 2011,85(9),4386-4398","journal-title":"J Virol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"e51089","DOI":"10.1371\/journal.pone.0051089","volume":"7","author":"Koishi A.C.","year":"2012","unstructured":"Koishi A.C.; Zanello P.R.; Bianco \u00c9.M.; Bordignon J.; Nunes Duarte dos Santos C.; Screening of Dengue virus antiviral activity of marine seaweeds by an in situ enzyme-linked immunosorbent assay. PLoS One 2012,7(12),e51089","journal-title":"PLoS One"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1186\/1743-422X-8-560","volume":"8","author":"Zandi K.","year":"2011","unstructured":"Zandi K.; Teoh B.T.; Sam S.S.; Wong P.F.; Mustafa M.R.; AbuBakar S.; Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol J 2011,8(1),560","journal-title":"Virol J"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1021\/jf901128u","volume":"57","author":"Ho H.Y.","year":"2009","unstructured":"Ho H.Y.; Cheng M.L.; Weng S.F.; Leu Y.L.; Chiu D.T.Y.; Antiviral effect of epigallocatechin gallate on enterovirus 71. J Agric Food Chem 2009,57(14),6140-6147","journal-title":"J Agric Food Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/hep.24610","volume":"54","author":"Ciesek S.","year":"2011","unstructured":"Ciesek S.; von Hahn T.; Colpitts C.C.; Schang L.M.; Friesland M.; Steinmann J.; Manns M.P.; Ott M.; Wedemeyer H.; Meuleman P.; Pietschmann T.; Steinmann E.; The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology 2011,54(6),1947-1955","journal-title":"Hepatology"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1472-765X.2010.02805.x","volume":"50","author":"Choi H.J.","year":"2010","unstructured":"Choi H.J.; Song J.H.; Park K.S.; Baek S.H.; In vitro anti-enterovirus 71 activity of gallic acid from Woodfordia fruticosa flowers. Lett Appl Microbiol 2010,50(4),438-440","journal-title":"Lett Appl Microbiol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/j.bmcl.2013.01.118","volume":"23","author":"Jiang Z.Y.","year":"2013","unstructured":"Jiang Z.Y.; Liu W.F.; Zhang X.M.; Luo J.; Ma Y.B.; Chen J.J.; Anti-HBV active constituents from Piper longum. Bioorg Med Chem Lett 2013,23(7),2123-2127","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/j.febslet.2010.04.067","volume":"584","author":"Mouler Rechtman M.","year":"2010","unstructured":"Mouler Rechtman M.; Har-Noy O.; Bar-Yishay I.; Fishman S.; Adamovich Y.; Shaul Y.; Halpern Z.; Shlomai A.; Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1\u03b1. FEBS Lett 2010,584(11),2485-2490","journal-title":"FEBS Lett"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.febslet.2009.12.019","volume":"584","author":"Kim K.","year":"2010","unstructured":"Kim K.; Kim K.H.; Kim H.Y.; Cho H.K.; Sakamoto N.; Cheong J.; Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. FEBS Lett 2010,584(4),707-712","journal-title":"FEBS Lett"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"7806","DOI":"10.1128\/JVI.00896-14","volume":"88","author":"Colpitts C.C.","year":"2014","unstructured":"Colpitts C.C.; Schang L.M.; A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans. J Virol 2014,88(14),7806-7817","journal-title":"J Virol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1142\/S0192415X13500092","volume":"41","author":"Zeng F.L.","year":"2013","unstructured":"Zeng F.L.; Xiang Y.F.; Liang Z.R.; Wang X.; Huang D.; Zhu S.N.; Li M.M.; Yang D.P.; Wang D.M.; Wang Y.F.; Anti-hepatitis B virus effects of dehydrocheilanthifoline from Corydalis saxicola. Am J Chin Med 2013,41(1),119-130","journal-title":"Am J Chin Med"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.antiviral.2004.12.006","volume":"66","author":"Chang J.","year":"2005","unstructured":"Chang J.; Liu H.; Wang K.; Chen M.; Chiang L.; Hua Y.; Lin C.; Ethanol extract of Polygonum cuspidatum inhibits hepatitis B virus in a stable HBV-producing cell line. Antiviral Res 2005,66(1),29-34","journal-title":"Antiviral Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jep.2012.09.003","volume":"144","author":"Hao B.J.","year":"2012","unstructured":"Hao B.J.; Wu Y.H.; Wang J.G.; Hu S.Q.; Keil D.J.; Hu H.J.; Lou J.D.; Zhao Y.; Hepatoprotective and antiviral properties of isochlorogenic acid A from Laggera alata against hepatitis B virus infection. J Ethnopharmacol 2012,144(1),190-194","journal-title":"J Ethnopharmacol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1073\/pnas.0914009107","volume":"107","author":"Polyak S.J.","year":"2010","unstructured":"Polyak S.J.; Morishima C.; Lohmann V.; Pal S.; Lee D.Y.W.; Liu Y.; Graf T.N.; Oberlies N.H.; Identification of hepatoprotective flavonolignans from silymarin. Proc Natl Acad Sci USA 2010,107(13),5995-5999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1053\/j.gastro.2007.02.038","volume":"132","author":"Polyak S.J.","year":"2007","unstructured":"Polyak S.J.; Morishima C.; Shuhart M.C.; Wang C.C.; Liu Y.; Lee D.Y.W.; Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin. Gastroenterology 2007,132(5),1925-1936","journal-title":"Gastroenterology"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"5159","DOI":"10.1128\/AAC.00633-11","volume":"55","author":"Meuleman P.","year":"2011","unstructured":"Meuleman P.; Albecka A.; Belouzard S.; Vercauteren K.; Verhoye L.; Wychowski C.; Leroux-Roels G.; Palmer K.E.; Dubuisson J.; Griffithsin has antiviral activity against hepatitis C virus. Antimicrob Agents Chemother 2011,55(11),5159-5167","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1053\/j.gastro.2012.03.036","volume":"143","author":"Haid S.","year":"2012","unstructured":"Haid S.; Novodomsk\u00e1 A.; Gentzsch J.; Grethe C.; Geuenich S.; Bankwitz D.; Chhatwal P.; Jannack B.; Hennebelle T.; Bailleul F.; A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes. Gastroenterology 2012,143(1),213-222. e215","journal-title":"Gastroenterology"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.bmcl.2010.01.084","volume":"20","author":"Tamura S.","year":"2010","unstructured":"Tamura S.; Yang G.M.; Yasueda N.; Matsuura Y.; Komoda Y.; Murakami N.; Tellimagrandin I.; HCV invasion inhibitor from Rosae rugosae Flos. Bioorg Med Chem Lett 2010,20(5),1598-1600","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.fitote.2010.11.022","volume":"82","author":"Gescher K.","year":"2011","unstructured":"Gescher K.; K\u00fchn J.; Hafezi W.; Louis A.; Derksen A.; Deters A.; Lorentzen E.; Hensel A.; Inhibition of viral adsorption and penetration by an aqueous extract from Rhododendron ferrugineum L. as antiviral principle against herpes simplex virus type-1. Fitoterapia 2011,82(3),408-413","journal-title":"Fitoterapia"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.tripleo.2011.04.007","volume":"112","author":"Danaher R.J.","year":"2011","unstructured":"Danaher R.J.; Wang C.; Dai J.; Mumper R.J.; Miller C.S.; Antiviral effects of blackberry extract against herpes simplex virus type 1. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011,112(3),e31-e35","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1099\/jmm.0.46110-0","volume":"55","author":"Cheng H.Y.","year":"2006","unstructured":"Cheng H.Y.; Yang C.M.; Lin T.C.; Shieh D.E.; Lin C.C.; ent-Epiafzelechin-(4\u03b1\u21928)-epiafzelechin extracted from Cassia javanica inhibits herpes simplex virus type 2 replication. J Med Microbiol 2006,55(2),201-206","journal-title":"J Med Microbiol"},{"key":"ref=78","volume":"2011","author":"Cheng H.-Y.","year":"2011","unstructured":"Cheng H.-Y.; Yang C.-M.; Lin T.-C.; Lin L.-T.; Chiang L.-C.; Lin C.-C.; Excoecarianin, isolated from Phyllanthus urinaria Linnea, inhibits herpes simplex virus type 2 infection through inactivation of viral particles. Evid Based Complement Alternat Med 2011,2011","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jep.2006.09.039","volume":"110","author":"Yang C.M.","year":"2007","unstructured":"Yang C.M.; Cheng H.Y.; Lin T.C.; Chiang L.C.; Lin C.C.; The in vitro activity of geraniin and 1,3,4,6-tetra-O-galloyl-\u03b2-d-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection. J Ethnopharmacol 2007,110(3),555-558","journal-title":"J Ethnopharmacol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/ptr.2232","volume":"21","author":"Yang C.M.","year":"2007","unstructured":"Yang C.M.; Cheng H.Y.; Lin T.C.; Chiang L.C.; Lin C.C.; Hippomanin a from acetone extract of Phyllanthus urinaria inhibited HSV-2 but not HSV-1 infection in vitro. Phytother Res 2007,21(12),1182-1186","journal-title":"Phytother Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.antiviral.2011.06.015","volume":"92","author":"Bertol J.W.","year":"2011","unstructured":"Bertol J.W.; Rigotto C.; de P\u00e1dua R.M.; Kreis W.; Barardi C.R.M.; Braga F.C.; Sim\u00f5es C.M.O.; Antiherpes activity of glucoevatromonoside, a cardenolide isolated from a Brazilian cultivar of Digitalis lanata. Antiviral Res 2011,92(1),73-80","journal-title":"Antiviral Res"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000119705","volume":"54","author":"Cheng H.Y.","year":"2008","unstructured":"Cheng H.Y.; Huang H.H.; Yang C.M.; Lin L.T.; Lin C.C.; The in vitro anti-herpes simplex virus type-1 and type-2 activity of Long Dan Xie Gan Tan, a prescription of traditional Chinese medicine. Chemotherapy 2008,54(2),77-83","journal-title":"Chemotherapy"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.antiviral.2007.08.012","volume":"77","author":"Cheng H.Y.","year":"2008","unstructured":"Cheng H.Y.; Lin L.T.; Huang H.H.; Yang C.M.; Lin C.C.; Hao Tang Y.C.; Yin Chen Hao Tang, a Chinese prescription, inhibits both herpes simplex virus type-1 and type-2 infections in vitro. Antiviral Res 2008,77(1),14-19","journal-title":"Antiviral Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jep.2012.03.024","volume":"141","author":"Lubbe A.","year":"2012","unstructured":"Lubbe A.; Seibert I.; Klimkait T.; van der Kooy F.; Ethnopharmacology in overdrive: The remarkable anti-HIV activity of Artemisia annua. J Ethnopharmacol 2012,141(3),854-859","journal-title":"J Ethnopharmacol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/ptr.2850","volume":"23","author":"Petrera E.","year":"2009","unstructured":"Petrera E.; Coto C.E.; Therapeutic effect of meliacine, an antiviral derived from Melia azedarach L., in mice genital herpetic infection. Phytother Res 2009,23(12),1771-1777","journal-title":"Phytother Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jep.2010.12.038","volume":"134","author":"Gescher K.","year":"2011","unstructured":"Gescher K.; K\u00fchn J.; Lorentzen E.; Hafezi W.; Derksen A.; Deters A.; Hensel A.; Proanthocyanidin-enriched extract from Myrothamnus flabellifolia. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration. J Ethnopharmacol 2011,134(2),468-474","journal-title":"J Ethnopharmacol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.bmcl.2012.12.034","volume":"23","author":"Kudo E.","year":"2013","unstructured":"Kudo E.; Taura M.; Matsuda K.; Shimamoto M.; Kariya R.; Goto H.; Hattori S.; Kimura S.; Okada S.; Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells. Bioorg Med Chem Lett 2013,23(3),606-609","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bmcl.2010.11.016","volume":"21","author":"Dao T.T.","year":"2011","unstructured":"Dao T.T.; Nguyen P.H.; Lee H.S.; Kim E.; Park J.; Lim S.I.; Oh W.K.; Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata. Bioorg Med Chem Lett 2011,21(1),294-298","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6882-11-16","volume":"11","author":"Krawitz C.","year":"2011","unstructured":"Krawitz C.; Mraheil M.A.; Stein M.; Imirzalioglu C.; Domann E.; Pleschka S.; Hain T.; Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses. BMC Complement Altern Med 2011,11(1),16","journal-title":"BMC Complement Altern Med"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.antiviral.2012.03.006","volume":"94","author":"Theisen L.L.","year":"2012","unstructured":"Theisen L.L.; Muller C.P.; EPs 7630 (Umckaloabo), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo. Antiviral Res 2012,94(2),147-156","journal-title":"Antiviral Res"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1248\/bpb.35.786","volume":"35","author":"Jeong H.J.","year":"2012","unstructured":"Jeong H.J.; Kim Y.M.; Kim J.H.; Kim J.Y.; Park J.Y.; Park S.J.; Ryu Y.B.; Lee W.S.; Homoisoflavonoids from Caesalpinia sappan displaying viral neuraminidases inhibition. Biol Pharm Bull 2012,35(5),786-790","journal-title":"Biol Pharm Bull"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1021\/ol401992s","volume":"15","author":"Ma S.G.","year":"2013","unstructured":"Ma S.G.; Gao R.M.; Li Y.H.; Jiang J.D.; Gong N.B.; Li L.; L\u00fc Y.; Tang W.Z.; Liu Y.B.; Qu J.; L\u00fc H.N.; Li Y.; Yu S.S.; Antiviral spirooliganones A and B with unprecedented skeletons from the roots of Illicium oligandrum. Org Lett 2013,15(17),4450-4453","journal-title":"Org Lett"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1016\/j.bmcl.2012.04.028","volume":"22","author":"Dao T.T.","year":"2012","unstructured":"Dao T.T.; Dang T.T.; Nguyen P.H.; Kim E.; Thuong P.T.; Oh W.K.; Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses. Bioorg Med Chem Lett 2012,22(11),3688-3692","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1142\/S0192415X97000123","volume":"25","author":"Huang S.P.","year":"1997","unstructured":"Huang S.P.; Shieh G.J.; Lee L.; Teng H.J.; Kao S.T.; Lin J.G.; Inhibition effect of shengma-gegen-tang on measles virus in Vero cells and human peripheral blood mononuclear cells. Am J Chin Med 1997,25(1),89-96","journal-title":"Am J Chin Med"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jep.2011.03.058","volume":"135","author":"Wang K.C.","year":"2011","unstructured":"Wang K.C.; Chang J.S.; Chiang L.C.; Lin C.C.; Sheng-Ma-Ge-Gen-Tang (Shoma-kakkon-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract. J Ethnopharmacol 2011,135(2),538-544","journal-title":"J Ethnopharmacol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1055\/s-1999-13971","volume":"65","author":"Lin Y.M.","year":"1999","unstructured":"Lin Y.M.; Flavin M.T.; Schure R.; Chen F.C.; Sidwell R.; Barnard D.I.; Huffmann J.H.; Kern E.R.; Antiviral activities of biflavonoids. Planta Med 1999,65(2),120-125","journal-title":"Planta Med"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1021\/np960017o","volume":"59","author":"Hayashi T.","year":"1996","unstructured":"Hayashi T.; Hayashi K.; Maeda M.; Kojima I.; Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis. J Nat Prod 1996,59(1),83-87","journal-title":"J Nat Prod"},{"key":"ref=98","first-page":"2","volume":"2","author":"Olila D.","year":"2002","unstructured":"Olila D.; Olwa-Odyek ; Opuda-Asibo J.; Screening extracts of Zanthoxylum chalybeum and Warburgia ugandensis for activity against measles virus (Swartz and Edmonston strains) in vitro. Afr Health Sci 2002,2(1),2-10","journal-title":"Afr Health Sci"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jep.2007.06.011","volume":"114","author":"Parker M.E.","year":"2007","unstructured":"Parker M.E.; Chabot S.; Ward B.J.; Johns T.; Traditional dietary additives of the Maasai are antiviral against the measles virus. J Ethnopharmacol 2007,114(2),146-152","journal-title":"J Ethnopharmacol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1142\/S0192415X12500127","volume":"40","author":"Wang K.C.","year":"2012","unstructured":"Wang K.C.; Chang J.S.; Chiang L.C.; Lin C.C.; Cimicifuga foetida L. inhibited human respiratory syncytial virus in HEp-2 and A549 cell lines. Am J Chin Med 2012,40(1),151-162","journal-title":"Am J Chin Med"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1055\/s-0031-1280128","volume":"78","author":"Wang Y.","year":"2012","unstructured":"Wang Y.; Chen M.; Zhang J.; Zhang X.L.; Huang X.J.; Wu X.; Zhang Q.W.; Li Y.L.; Ye W.C.; Flavone C-glycosides from the leaves of Lophatherum gracile and their in vitro antiviral activity. Planta Med 2012,78(1),46-51","journal-title":"Planta Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"13061","DOI":"10.1128\/JVI.05869-11","volume":"85","author":"Zang N.","year":"2011","unstructured":"Zang N.; Xie X.; Deng Y.; Wu S.; Wang L.; Peng C.; Li S.; Ni K.; Luo Y.; Liu E.; Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice. J Virol 2011,85(24),13061-13068","journal-title":"J Virol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"153476","DOI":"10.1016\/j.phymed.2021.153476","volume":"85","author":"Oesch F.","year":"2021","unstructured":"Oesch F.; Oesch-Bartlomowicz B.; Efferth T.; Toxicity as prime selection criterion among SARS-active herbal medications. Phytomedicine 2021,85,153476","journal-title":"Phytomedicine"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"106012","DOI":"10.1016\/j.ijantimicag.2020.106012","volume":"56","author":"Yu R.","year":"2020","unstructured":"Yu R.; Chen L.; Lan R.; Shen R.; Li P.; Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking. Int J Antimicrob Agents 2020,56(2),106012","journal-title":"Int J Antimicrob Agents"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.3390\/molecules25081876","volume":"25","author":"Thabti I.","year":"2020","unstructured":"Thabti I.; Albert Q.; Philippot S.; Dupire F.; Westerhuis B.; Fontanay S.; Risler A.; Kassab T.; Elfalleh W.; Aferchichi A.; Varbanov M.; Advances on antiviral activity of Morus spp. plant extracts: human coronavirus and virus-related respiratory tract infections in the spotlight. Molecules 2020,25(8),1876","journal-title":"Molecules"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijbiomac.2016.10.002","volume":"94","author":"Ming K.","year":"2017","unstructured":"Ming K.; Chen Y.; Yao F.; Shi J.; Yang J.; Du H.; Wang X.; Wang Y.; Liu J.; Phosphorylated Codonopsis pilosula polysaccharide could inhibit the virulence of duck hepatitis A virus compared with Codonopsis pilosula polysaccharide. Int J Biol Macromol 2017,94(Pt A),28-35","journal-title":"Int J Biol Macromol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/v10090471","volume":"10","author":"Wang Y.","year":"2018","unstructured":"Wang Y.; Jung Y.J.; Kim K.H.; Kwon Y.; Kim Y.J.; Zhang Z.; Kang H.S.; Wang B.Z.; Quan F.S.; Kang S.M.; Antiviral activity of fermented ginseng extracts against a broad range of influenza viruses. Viruses 2018,10(9),471","journal-title":"Viruses"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230125121758","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/213137\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230125121758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T01:00:20Z","timestamp":1728781220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/213137\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867330666230125121758","relation":{},"ISSN":["0929-8673"],"issn-type":[{"type":"print","value":"0929-8673"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-05-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}